학술논문
BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic leukemia/lymphoma: reduced myelosuppression and GVHD
Document Type
Article
Author
Source
In Blood 2 October 2014 124(14):2306-2312
Subject
Language
ISSN
0006-4971